Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001438588-13-000031)

Filing Details

Accession Number:: 0001438588-13-000031
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-19 16:55:41
Reporting Period:: 2013-04-18

Filing Date:: 2013-04-19
Accepted Time:: 2013-04-19 16:55:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
791908	Xoma Corp	XOMA	Pharmaceutical Preparations (2834)	942756657

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1210905	D Paul Rubin	C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710	Sr. Vp Clinical Dev. & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2013-04-18	6,000	$0.00	8,749	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	4,422	Indirect	by 401(k)

Footnotes

This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2013.
These shares were disposed of in multiple transactions at prices ranging from $3.21 to $3.37 for aggregate gross proceeds of $19,633.50.